Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 and certain immune cells are linked to more severe alopecia areata.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

New treatments for alopecia areata, like JAK inhibitors and immunomodulators, are promising.

T-cell patterns in skin help distinguish alopecia areata from androgenetic alopecia.

Trichoepitheliomas and some basal cell carcinomas likely come from hair follicle stem cells.

Recognizing diverse presentations of folliculotropic mycosis fungoides is crucial to avoid diagnostic errors.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

The model showed that immune system guardians and the cytokine interferon-γ are key in alopecia areata progression.

Autoimmune reactions may cause both alopecia areata and HAM.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Clonally expanded CD8+ T cells cause alopecia areata.

HPV8 E6 gene causes growth of certain skin stem cells.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.